Perfusion-selected late thrombectomy, trauma CT caution, ovarian cancer biomarker sequencing and post-ICU trauma checks.
A rapid negative trauma CT report is not the same as a definitive final clearance when the clinical examination remains concerning.
Today’s acute-care learning spans delayed stroke decisions and trauma workflow. Very-late large vessel occlusion stroke should not be reduced to clock time alone: last known well remains essential, but perfusion mismatch, small infarct core, large at-risk tissue, good collaterals and disabling deficit determine whether specialist thrombectomy discussion is appropriate. The table also highlights why conference data should not be converted into routine pathway change before full publication and replication, particularly when functional benefit sits beside higher symptomatic haemorrhage and mortality signals.
Trauma teams get a practical workflow reminder. A rapid early CT report can function like an imaging primary survey for immediately life-threatening injury, but discharge or definitive disposition still requires clinical correlation, report-status awareness, radiology discussion and senior review when symptoms, mechanism or examination remain concerning. Minimal-movement log rolling also becomes a safety intervention: ask whether anyone is not ready, move only as much as needed, and keep the head end leading.
The oncology item focuses on platinum-resistant ovarian cancer, where the traditional six-month cut-off remains useful but insufficient. Treatment selection now includes biomarker status, prior response, disease tempo, toxicity, treatment schedule, trial access and patient priorities. The post-ICU recovery episode adds the human side of serious illness: stable investigations do not exclude nightmares, anxiety, avoidance, pain, reduced bandwidth or a need for clearer navigation.

Emergency and trauma teams get practical material on trauma CT interpretation, post-CT team leadership and safer patient movement. Rapid preliminary reports are framed as an imaging primary survey, while minimal-movement log rolling and specific positive feedback support safer trauma workflow.

Neurology, emergency medicine and radiology teams get a concise appraisal of very-late thrombectomy in large vessel occlusion stroke. The episode keeps last known well, deficit severity, perfusion mismatch, infarct core, collateral status, functional outcome, symptomatic haemorrhage and mortality in the same decision frame.

Oncology and gynaecology teams get a treatment-sequencing update for platinum-resistant ovarian cancer. Folate receptor alpha testing, mirvetuximab soravtansine, ocular toxicity, immunotherapy combinations, glucocorticoid receptor antagonism, response need and time toxicity all shape patient-centred decisions.

Critical-care, human-factors and medical-education readers get a patient-centred recovery piece on life after severe illness. Nightmares, avoidance, embodied distress, reduced health literacy, procedural support and care navigation are linked to the limits of test-based definitions of healing.
After trauma CT, build in a deliberate pause before disposition. Confirm whether the report is preliminary or senior reviewed, correlate it with the mechanism and examination, speak with radiology when concern persists, and assign ownership of the next action. For late-presenting stroke, document last known well, deficit severity and trajectory clearly so advanced imaging and specialist decisions are not delayed.
A patient presents 38 hours after last known well with disabling anterior-circulation large vessel occlusion. What imaging features support specialist discussion about very-late thrombectomy?
A small infarct core, large perfusion mismatch, substantial at-risk tissue and good collateral circulation support specialist discussion. Very-late thrombectomy should not be applied to unselected delayed presentations.
A stable trauma patient has a rapid CT report showing no immediately life-threatening injury, but focal pain and mechanism remain concerning. What is the safest next step before discharge?
Review the images where possible, correlate with the examination, clarify report status, speak with radiology and await appropriate senior or full reporting before using the scan to support discharge.
A patient with folate receptor alpha-positive platinum-resistant ovarian cancer is being considered for mirvetuximab soravtansine. What toxicity needs proactive counselling and monitoring?
Ocular toxicity, including visual blurring, ocular discomfort and keratitis, needs proactive counselling, symptom checks and monitoring alongside eligibility confirmation.